Key facts
- This page summarizes Jonathan E. Lim's Form 4 filing for Erasca, Inc. (ERAS).
- 6 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 20 Jul 2021, 20:58.
Jonathan E. Lim - 20 Jul 2021 Form 4 Insider Report for Erasca, Inc. (ERAS)
- Reporting relationship
- Chairman and Chief Executive Officer, Director, 10%+ Owner
- Issuer ticker
- ERAS
- Reported as of
- 20 Jul 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Jul 2021, 20:58:45 UTC
- Prior SEC filing
- 15 Jul 2021
- Next SEC filing
- 03 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ebun S. Garner, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan E. Lim filed Form 4 for Erasca, Inc. (ERAS) on 20 Jul 2021.
Change
- Previous filing in this sequence was filed on 15 Jul 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ERAS
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +5,135,390
- Change %
- +34%
- Price
- Shares after
- 20,156,222
- Date
- 20 Jul 2021
- Ownership
- By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005
- Footnotes
- F1, F2
ERAS
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +5,441,027
- Change %
- +84%
- Price
- Shares after
- 11,899,360
- Date
- 20 Jul 2021
- Ownership
- By City Hill, LLC
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ERAS
transaction
Derivative
Series A Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -6,162,468
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Jul 2021
- Ownership
- By the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005
- Underlying class
- Common Stock
- Underlying amount
- 5,135,390
- Exercise price
- $0.000000
- Footnotes
- F1, F2
ERAS
transaction
Derivative
Series A Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -6,081,233
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Jul 2021
- Ownership
- By City Hill, LLC
- Underlying class
- Common Stock
- Underlying amount
- 5,067,694
- Exercise price
- $0.000000
- Footnotes
- F1, F3
ERAS
transaction
Derivative
Series B-1 Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -336,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Jul 2021
- Ownership
- By City Hill, LLC
- Underlying class
- Common Stock
- Underlying amount
- 280,000
- Exercise price
- $0.000000
- Footnotes
- F1, F3
ERAS
transaction
Derivative
Series B-2 Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -112,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Jul 2021
- Ownership
- By City Hill, LLC
- Underlying class
- Common Stock
- Underlying amount
- 93,333
- Exercise price
- $0.000000
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering.
Footnote F2
The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
Footnote F3
Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.
SEC remarks
Chairman and Chief Executive Officer